Transcriptional and Epigenetic Regulation of Context-Dependent Plasticity in T-Helper Lineages

키워드

참고문헌 (149)

1. Nair SJ, "Transcriptional enhancers at 40 : evolution of a viral DNA element to nuclear architectural structures", Trends Genet, 38, pp.1019~1047 (2022)
2. Zheng H, "The role of 3D genome organization in development and cell differentiation", Nat Rev Mol Cell Biol, 20, pp.535~550 (2019)
3. Bai L, "DNA methylation in regulatory T cell differentiation and function : challenges and opportunities", Biomolecules, 12, pp.1282~ (2022)
4. Waldman AD, "A guide to cancer immunotherapy : from T cell basic science to clinical practice", Nat Rev Immunol, 20, pp.651~668 (2020)
5. Grosser R, "Combination immunotherapy with CAR T cells and checkpoint blockade for the treatment of solid tumors", Cancer Cell, 36, pp.471~482 (2019)
6. Gun SY, "Targeting immune cells for cancer therapy", Redox Biol, 25, pp.101174~ (2019)
7. Cavalli G, "Advances in epigenetics link genetics to the environment and disease", Nature, 571, pp.489~499 (2019)
8. Nakamura M, "CRISPR technologies for precise epigenome editing", Nat Cell Biol, 23, pp.11~22 (2021)
9. Lyko F, "The DNA methyltransferase family : a versatile toolkit for epigenetic regulation", Nat Rev Genet, 19, pp.81~92 (2018)
10. Allaman-Pillet N, "Methylation status of CpG sites and methyl-CpG binding proteins are involved in the promoter regulation of the mouse Xist gene", Gene Expr, 7, pp.61~73 (1998)
11. Lister R, "Human DNA methylomes at base resolution show widespread epigenomic differences", Nature, 462, pp.315~322 (2009)
12. Vaisvila R, "Enzymatic methyl sequencing detects DNA methylation at single-base resolution from picograms of DNA", Genome Res, 31, pp.1280~1289 (2021)
13. Gouil Q, "Latest techniques to study DNA methylation", Essays Biochem, 63, pp.639~648 (2019)
14. Masser DR, "Focused, high accuracy 5-methylcytosine quantitation with base resolution by benchtop next-generation sequencing", Epigenetics Chromatin, 6, pp.33~ (2013)
15. Meyer CA, "Identifying and mitigating bias in next-generation sequencing methods for chromatin biology", Nat Rev Genet, 15, pp.709~721 (2014)
16. Miraldi ER, "Leveraging chromatin accessibility for transcriptional regulatory network inference in T Helper 17 Cells", Genome Res, 29, pp.449~463 (2019)
17. Hall JA, "Transcription factor RORα enforces stability of the Th17 cell effector program by binding to a Rorc cis-regulatory element", Immunity, 55, pp.2027~2043 (2022)
18. Chen X, "The histone methyltransferase EZH2 primes the early differentiation of follicular helper T cells during acute viral infection", Cell Mol Immunol, 17, pp.247~260 (2020)
19. Hertweck A, "The TH1 cell lineage-determining transcription factor T-bet suppresses TH2 gene expression by redistributing GATA3 away from TH2 genes", Nucleic Acids Res, 50, pp.4557~4573 (2022)
20. DiSpirito JR, "Molecular diversification of regulatory T cells in nonlymphoid tissues", Sci Immunol, 3 (2018)
21. Johnson DS, "Genome-wide mapping of in vivo protein-DNA interactions", Science, 316, pp.1497~1502 (2007)
22. Kaya-Okur HS, "CUT&Tag for efficient epigenomic profiling of small samples and single cells", Nat Commun, 10, pp.1930~ (2019)
23. Skene PJ, "An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites", eLife, 6, pp.6~ (2017)
24. Gopalan S, "Simultaneous profiling of multiple chromatin proteins in the same cells", Mol Cell, 81, pp.4736~4746 (2021)
25. Ranzani V, "The long intergenic noncoding RNA landscape of human lymphocytes highlights the regulation of T cell differentiation by linc-MAF-4", Nat Immunol, 16, pp.318~325 (2015)
26. Taheri M, "Emerging role of non-coding RNAs in regulation of T-lymphocyte function", Front Immunol, 12, pp.756042~ (2021)
27. Gibbons HR, "Divergent lncRNA", Front Immunol, 9, pp.2512~ (2018)
28. Zhao Y, "NONCODE 2016 : an informative and valuable data source of long non-coding RNAs", Nucleic Acids Res, 44, pp.D203~D208 (2016)
29. Wright C, "Comprehensive assessment of multiple biases in small RNA sequencing reveals significant differences in the performance of widely used methods", BMC Genomics, 20, pp.513~ (2019)
30. Benesova S, "Small RNA-sequencing : approaches and considerations for miRNA analysis", Diagnostics(Basel), 11, pp.964~ (2021)
31. Wissink EM, "Nascent RNA analyses : tracking transcription and its regulation", Nat Rev Genet, 20, pp.705~723 (2019)
32. Lee JH, "Enhancer RNAs in cancer : regulation, mechanisms and therapeutic potential", RNA Biol, 17, pp.1550~1559 (2020)
33. Oh S, "Enhancer release and retargeting activates disease-susceptibility genes", Nature, 595, pp.735~740 (2021)
34. Friedman Meyer J., "Dynamics of Viral and Host 3D Genome Structure upon Infection", Journal of Microbiology and Biotechnology, 32(12), pp.1515~1526 (2022), 한국미생물·생명공학회[DOI]
35. Cuartero S, "Three-dimensional genome organization in immune cell fate and function", Nat Rev Immunol (2022)
36. Tian Y, "SOX-5 activates a novel RORγt enhancer to facilitate experimental autoimmune encephalomyelitis by promoting Th17 cell differentiation", Nat Commun, 12, pp.481~ (2021)
37. Ren G, "CTCF-mediated enhancer-promoter interaction is a critical regulator of cell-to-cell variation of gene expression", Mol Cell, 67, pp.1049~1058 (2017)
38. Chen Y, "DNA binding by FOXP3 domain-swapped dimer suggests mechanisms of long-range chromosomal interactions", Nucleic Acids Res, 43, pp.1268~1282 (2015)
39. Hakim O, "Spatial congregation of STAT binding directs selective nuclear architecture during T-cell functional differentiation", Genome Res, 23, pp.462~472 (2013)
40. Issuree PD, "Heritable gene regulation in the CD4 : CD8 T cell lineage choice", Front Immunol, 8, pp.291~ (2017)
41. Wei G, "Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells", Immunity, 30, pp.155~167 (2009)
42. Avni O, "T(H)cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes", Nat Immunol, 3, pp.643~651 (2002)
43. Melvin AJ, "Hypomethylation of the interferon-gamma gene correlates with its expression by primary T-lineage cells", Eur J Immunol, 25, pp.426~430 (1995)
44. Thomas RM, "De novo DNA methylation is required to restrict T helper lineage plasticity", J Biol Chem, 287, pp.22900~22909 (2012)
45. Zhu J, "Differentiation of effector CD4 T cell populations", Annu Rev Immunol, 28, pp.445~489 (2010)
46. Fields PE, "Cutting edge : changes in histone acetylation at the IL-4 and IFN-gamma loci accompany Th1", Th2 differentiation, 2002, pp.169, 647~650
47. Vahedi G, "Super-enhancers delineate disease-associated regulatory nodes in T cells", Nature, 520, pp.558~562 (2015)
48. Lee S, "RORγt-driven TH17 cell differentiation requires epigenetic control by the Swi", Snf chromatin remodeling complex, 2020, pp.23, 101106~
49. Kanno Y, "Transcriptional and epigenetic control of T helper cell specification : molecular mechanisms underlying commitment and plasticity", Annu Rev Immunol, 30, pp.707~731 (2012)
50. Vahedi G, "STATs shape the active enhancer landscape of T cell populations", Cell, 151, pp.981~993 (2012)
51. Lazarevic V, "T-bet : a bridge between innate and adaptive immunity", Nat Rev Immunol, 13, pp.777~789 (2013)
52. Hermann-Kleiter N, "NFAT pulls the strings during CD4+ T helper cell effector functions", Blood, 115, pp.2989~2997 (2010)
53. Placek K, "Genetic and epigenetic networks controlling T helper 1 cell differentiation", Immunology, 127, pp.155~162 (2009)
54. Li Q, "Critical role of histone demethylase Jmjd3 in the regulation of CD4+ T-cell differentiation", Nat Commun, 5, pp.5780~ (2014)
55. Zhu J, "The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses", Immunity, 37, pp.660~673 (2012)
56. Hadjur S, "Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus", Nature, 460, pp.410~413 (2009)
57. Walker JA, "TH2 cell development and function", Nat Rev Immunol, 18, pp.121~133 (2018)
58. Wei L, "Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation", Immunity, 32, pp.840~851 (2010)
59. Onodera A, "Epigenetic and transcriptional regulation in the induction, maintenance, heterogeneity, and recall-response of effector and memory Th2 cells", Front Immunol, 9, pp.2929~ (2018)
60. Ho IC, "Regulation of IL-4 expression in immunity and diseases", Adv Exp Med Biol, 941, pp.31~77 (2016)
61. Fang D, "Bcl11b, a novel GATA3-interacting protein, suppresses Th1 while limiting Th2 cell differentiation", J Exp Med, 215, pp.1449~1462 (2018)
62. Hosokawa H, "Methylation of Gata3 protein at Arg-261 regulates transactivation of the Il5 gene in T helper 2 cells", J Biol Chem, 290, pp.13095~13103 (2015)
63. Nakayama T, "Th2 cells in health and disease", Annu Rev Immunol, 35, pp.53~84 (2017)
64. Spilianakis CG, "Interchromosomal associations between alternatively expressed loci", Nature, 435, pp.637~645 (2005)
65. "Deletion mapping of regulatory elements for GATA3 reveals a distal T helper 2 cell enhancer involved in allergic diseases"[URL]
66. Akuzum Begum, "Context-Dependent Regulation of Type17 Immunity by Microbiota at the Intestinal Barrier", Immune Network, 22(6), pp.1~25 (2022), 대한면역학회[DOI]
67. Capone A, "Transcriptional regulators of T helper 17 cell differentiation in health and autoimmune diseases", Front Immunol, 11, pp.348~ (2020)
68. Chang D, "The conserved non-coding sequences CNS6 and CNS9 control cytokine-induced Rorc transcription during T helper 17 cell differentiation", Immunity, 53, pp.614~626 (2020)
69. Kumar R, "RORγt protein modifications and IL-17-mediated inflammation", Trends Immunol, 42, pp.1037~1050 (2021)
70. Olatunde AC, "Cytokine-skewed Tfh cells : functional consequences for B cell help", Trends Immunol, 42, pp.536~550 (2021)
71. 전윤희, "Follicular Helper T (Tfh) Cells in Autoimmune Diseases and Allograft Rejection", Immune Network, 16(4), pp.219~232 (2016), 대한면역학회[DOI]
72. Choi YS, "Dynamic regulation of Bcl6 in follicular helper CD4 T(Tfh)cells", Curr Opin Immunol, 25, pp.366~372 (2013)
73. Choi YS, "Cutting edge : STAT1 is required for IL-6-mediated Bcl6 induction for early follicular helper cell differentiation", J Immunol, 190, pp.3049~3053 (2013)
74. Nakayamada S, "Early Th1 cell differentiation is marked by a Tfh cell-like transition", Immunity, 35, pp.919~931 (2011)
75. Choi J, "Bcl6-mediated transcriptional regulation of follicular helper T cells(TFH)", Trends Immunol, 42, pp.336~349 (2021)
76. Stone EL, "ICOS coreceptor signaling inactivates the transcription factor FOXO1 to promote Tfh cell differentiation", Immunity, 42, pp.239~251 (2015)
77. Choi J, "Bcl-6 is the nexus transcription factor of T follicular helper cells via repressor-of-repressor circuits", Nat Immunol, 21, pp.777~789 (2020)
78. Bunting KL, "Multi-tiered reorganization of the genome during B cell affinity maturation anchored by a germinal center-specific locus control region", Immunity, 45, pp.497~512 (2016)
79. 이원용, "Transcriptional regulation and development of regulatory T cells", Experimental and Molecular Medicine, 50, pp.1~10 (2018), 생화학분자생물학회
80. Hagihara Y, "Epigenetic regulation of T helper cells and intestinal pathogenicity", Semin Immunopathol, 41, pp.379~399 (2019)
81. Someya K, "Improvement of Foxp3 stability through CNS2 demethylation by TET enzyme induction and activation", Int Immunol, 29, pp.365~375 (2017)
82. Kawakami R, "Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells", Immunity, 54, pp.947~961 (2021)
83. Deng G, "FoxP3 in Treg cell biology : a molecular and structural perspective", Clin Exp Immunol, 199, pp.255~262 (2020)
84. Dong Y, "Post-translational regulations of Foxp3 in Treg cells and their therapeutic applications", Front Immunol, 12, pp.626172~ (2021)
85. Rudra D, "Transcription factor Foxp3 and its protein partners form a complex regulatory network", Nat Immunol, 13, pp.1010~1019 (2012)
86. Colamatteo A, "Molecular mechanisms controlling foxp3 expression in health and autoimmunity : from epigenetic to post-translational regulation", Front Immunol, 10, pp.3136~ (2020)
87. Ramirez RN, "FoxP3 associates with enhancer-promoter loops to regulate Treg-specific gene expression", Sci Immunol, 7 (2022)
88. Kwon HK, "Different molecular complexes that mediate transcriptional induction and repression by FoxP3", Nat Immunol, 18, pp.1238~1248 (2017)
89. Yoshida H, "The cis-regulatory atlas of the mouse immune system", Cell, 176, pp.897~912 (2019)
90. Peine M, "Stable T-bet(+)GATA-3(+)Th1", Th2 hybrid cells arise in vivo, can develop directly from naive precursors, and limit immunopathologic inflammation, 2013, pp.11, e1001633~
91. Burt P, "Dissecting the dynamic transcriptional landscape of early T helper cell differentiation into Th1, Th2, and Th1", 2 hybrid cells, 2022, pp.13, 928018~
92. Ghoreschi K, "Generation of pathogenic T(H)17 cells in the absence of TGF-β signalling", Nature, 467, pp.967~971 (2010)
93. Cosmi L, "Identification of a novel subset of human circulating memory CD4(+)T cells that produce both IL-17A and IL-4", J Allergy Clin Immunol, 125, pp.222~230 (2010)
94. Mirlekar B, "Co-expression of master transcription factors determines CD4+ T cell plasticity and functions in auto-inflammatory diseases", Immunol Lett, 222, pp.58~66 (2020)
95. Harbour SN, "Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis", Proc Natl Acad Sci U S A, 112, pp.7061~7066 (2015)
96. Yang BH, "Development of a unique epigenetic signature during in vivo Th17 differentiation", Nucleic Acids Res, 43, pp.1537~1548 (2015)
97. Obermajer N, "Conversion of Th17 into IL-17A(neg)regulatory T cells : a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy", J Immunol, 193, pp.4988~4999 (2014)
98. Mazzoni A, "Demethylation of the RORC2 and IL17A in human CD4+ T lymphocytes defines Th17 origin of nonclassic Th1 cells", J Immunol, 194, pp.3116~3126 (2015)
99. Mukasa R, "Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage", Immunity, 32, pp.616~627 (2010)
100. Lee YK, "Late developmental plasticity in the T helper 17 lineage", Immunity, 30, pp.92~107 (2009)
101. Zheng W, "The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells", Cell, 89, pp.587~596 (1997)
102. Fontenot JD, "Foxp3 programs the development and function of CD4+CD25+ regulatory T cells", Nat Immunol, 4, pp.330~336 (2003)
103. Bam M, "Genome wide DNA methylation landscape reveals glioblastoma’s influence on epigenetic changes in tumor infiltrating CD4+ T cells", Oncotarget, 12, pp.967~981 (2021)
104. Wang D, "Targeting EZH2 reprograms intratumoral regulatory T cells to enhance cancer immunity", Cell Reports, 23, pp.3262~3274 (2018)
105. Weisenberger DJ, "The role of DNA methylation and DNA methyltransferases in cancer", Adv Exp Med Biol, 1389, pp.317~348 (2022)
106. Yu X, "The novel long noncoding RNA u50535 promotes colorectal cancer growth and metastasis by regulating CCL20", Cell Death Dis, 9, pp.751~ (2018)
107. Vitiello GA, "Targeting the interleukin-17 immune axis for cancer immunotherapy", J Exp Med, 217, pp.e20190456~ (2020)
108. Sasidharan Nair V, "Impact of gut microenvironment on epigenetic signatures of intestinal T helper cell subsets", Immunol Lett, 246, pp.27~36 (2022)
109. Yang P, "Th17 cell pathogenicity and plasticity in rheumatoid arthritis", J Leukoc Biol, 106, pp.1233~1240 (2019)
110. Morrison PJ, "Th17-cell plasticity in Helicobacter hepaticus-induced intestinal inflammation", Mucosal Immunol, 6, pp.1143~1156 (2013)
111. Fu SH, "Interplay between cytokine circuitry and transcriptional regulation shaping helper T cell pathogenicity and plasticity in inflammatory bowel disease", Int J Mol Sci, 21, pp.3379~ (2020)
112. Belpaire A, "From IL-17 to IFN-γ in inflammatory skin disorders : is transdifferentiation a potential treatment target?", Front Immunol, 13, pp.932265~ (2022)
113. Bhaskaran N, "Identification of Casz1 as a regulatory protein controlling T helper cell differentiation, inflammation, and immunity", Front Immunol, 9, pp.184~ (2018)
114. Brucklacher-Waldert V, "Tbet or continued RORγt expression is not required for Th17-associated immunopathology", J Immunol, 196, pp.4893~4904 (2016)
115. Quandt J, "Wnt-β-catenin activation epigenetically reprograms Treg cells in inflammatory bowel disease and dysplastic progression", Nat Immunol, 22, pp.471~484 (2021)
116. Saxena V, "Mechanisms of exTreg induction", Eur J Immunol, 51, pp.1956~1967 (2021)
117. Tseng WY, "TNF receptor 2 signaling prevents DNA methylation at the Foxp3 promoter and prevents pathogenic conversion of regulatory T cells", Proc Natl Acad Sci U S A, 116, pp.21666~21672 (2019)
118. Xia M, "Ash1l and lnc-Smad3 coordinate Smad3 locus accessibility to modulate iTreg polarization and T cell autoimmunity", Nat Commun, 8, pp.15818~ (2017)
119. Ganesan A, "The timeline of epigenetic drug discovery : from reality to dreams", Clin Epigenetics, 11, pp.174~ (2019)
120. Deaton AM, "CpG islands and the regulation of transcription", Genes Dev, 25, pp.1010~1022 (2011)
121. Yang X, "Gene body methylation can alter gene expression and is a therapeutic target in cancer", Cancer Cell, 26, pp.577~590 (2014)
122. Heyn H, "Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer", Genome Biol, 17, pp.11~ (2016)
123. Cabezón M, "Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival", Clin Epigenetics, 13, pp.9~ (2021)
124. Diesch J, "A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers", Clin Epigenetics, 8, pp.71~ (2016)
125. Pappalardi MB, "Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia", Nat Can, 2, pp.1002~1017 (2021)
126. Ebelt ND, "5-Azacytidine potentiates anti-tumor immunity in a model of pancreatic ductal adenocarcinoma", Front Immunol, 11, pp.538~ (2020)
127. Chiappinelli KB, "Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses", Cell, 162, pp.974~986 (2015)
128. Lemonnier F, "Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma", Blood, 132, pp.2305~2309 (2018)
129. Sánchez-Abarca LI, "Immunomodulatory effect of 5-azacytidine(5-azaC) : potential role in the transplantation setting", Blood, 115, pp.107~121 (2010)
130. Bondarev AD, "Recent developments of HDAC inhibitors : emerging indications and novel molecules", Br J Clin Pharmacol, 87, pp.4577~4597 (2021)
131. Zhang F, "Epigenetic manipulation restores functions of defective CD8+ T cells from chronic viral infection", Mol Ther, 22, pp.1698~1706 (2014)
132. Woods DM, "HDAC inhibition upregulates PD-1 ligands in melanoma and augments immunotherapy with PD-1 blockade", Cancer Immunol Res, 3, pp.1375~1385 (2015)
133. Lange UC, "Epigenetic crosstalk in chronic infection with HIV-1", Semin Immunopathol, 42, pp.187~200 (2020)
134. Abner E, "HIV"shock and kill"therapy : in need of revision", Antiviral Res, 166, pp.19~34 (2019)
135. Rezai-Zadeh K, "CNS infiltration of peripheral immune cells : D-Day for neurodegenerative disease?", J Neuroimmune Pharmacol, 4, pp.462~475 (2009)
136. Andrieu G, "Clinical trials for BET inhibitors run ahead of the science", Drug Discov Today Technol, 19, pp.45~50 (2016)
137. Shorstova T, "Achieving clinical success with BET inhibitors as anti-cancer agents", Br J Cancer, 124, pp.1478~1490 (2021)
138. Mele DA, "BET bromodomain inhibition suppresses TH17-mediated pathology", J Exp Med, 210, pp.2181~2190 (2013)
139. Ferreira de Freitas R, "Methyltransferase inhibitors : competing with, or exploiting the bound cofactor", Molecules, 24, pp.4492~ (2019)
140. Feng FY, "Chromatin to clinic : the molecular rationale for PARP1 inhibitor function", Mol Cell, 58, pp.925~934 (2015)
141. Rose M, "PARP inhibitors : clinical relevance, mechanisms of action and tumor resistance", Front Cell Dev Biol, 8, pp.564601~ (2020)
142. Nasta F, "Increased Foxp3+ regulatory T cells in poly(ADP-Ribose)polymerase-1 deficiency", J Immunol, 184, pp.3470~3477 (2010)
143. Luo X, "Poly(ADP-ribosyl)ation of FOXP3 protein mediated by PARP-1 protein regulates the function of regulatory T cells", J Biol Chem, 290, pp.28675~28682 (2015)
144. Rosenberg SA, "Adoptive cell transfer as personalized immunotherapy for human cancer", Science, 348, pp.62~68 (2015)
145. Zhao Z, "Adaptable leukemia cells resisting CAR T-cell attack via B-cell activation", Cancer Immunol Res, 10, pp.1040~ (2022)
146. Rurik JG, "Uniting disciplines to develop therapeutics : targeted mRNA lipid nanoparticles reprogram the immune system in vivo to treat heart disease", DNA Cell Biol, 41, pp.539~543 (2022)
147. Raffin C, "Treg cell-based therapies : challenges and perspectives", Nat Rev Immunol, 20, pp.158~172 (2020)
148. Gilbert LA, "CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes", Cell, 154, pp.442~451 (2013)
149. Konermann S, "Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex", Nature, 517, pp.583~588 (2015)

관련 논문AI추천